Cargando…

Epigenetic Regulations in Diabetic Nephropathy

Diabetic nephropathy (DN) is a chronic complication of diabetes and the most common cause of end-stage kidney disease. It has been reported that multiple factors are involved in the pathogenesis of DN, while the molecular mechanisms that lead to DN are still not fully understood. Numerous risk facto...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Zeyuan, Liu, Na, Wang, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5376412/
https://www.ncbi.nlm.nih.gov/pubmed/28401169
http://dx.doi.org/10.1155/2017/7805058
_version_ 1782519152426090496
author Lu, Zeyuan
Liu, Na
Wang, Feng
author_facet Lu, Zeyuan
Liu, Na
Wang, Feng
author_sort Lu, Zeyuan
collection PubMed
description Diabetic nephropathy (DN) is a chronic complication of diabetes and the most common cause of end-stage kidney disease. It has been reported that multiple factors are involved in the pathogenesis of DN, while the molecular mechanisms that lead to DN are still not fully understood. Numerous risk factors for the development of diabetic nephropathy have been proposed, including ethnicity and inherited genetic differences. Recently, with the development of high-throughput technologies, there is emerging evidence that suggests the important role of epigenetic mechanisms in the pathogenesis of DN. Epigenetic regulations, including DNA methylation, noncoding RNAs, and histone modifications, play a pivotal role in DN pathogenesis by a second layer of gene regulation. All these findings can contribute to developing novel therapies for DN.
format Online
Article
Text
id pubmed-5376412
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-53764122017-04-11 Epigenetic Regulations in Diabetic Nephropathy Lu, Zeyuan Liu, Na Wang, Feng J Diabetes Res Review Article Diabetic nephropathy (DN) is a chronic complication of diabetes and the most common cause of end-stage kidney disease. It has been reported that multiple factors are involved in the pathogenesis of DN, while the molecular mechanisms that lead to DN are still not fully understood. Numerous risk factors for the development of diabetic nephropathy have been proposed, including ethnicity and inherited genetic differences. Recently, with the development of high-throughput technologies, there is emerging evidence that suggests the important role of epigenetic mechanisms in the pathogenesis of DN. Epigenetic regulations, including DNA methylation, noncoding RNAs, and histone modifications, play a pivotal role in DN pathogenesis by a second layer of gene regulation. All these findings can contribute to developing novel therapies for DN. Hindawi 2017 2017-03-19 /pmc/articles/PMC5376412/ /pubmed/28401169 http://dx.doi.org/10.1155/2017/7805058 Text en Copyright © 2017 Zeyuan Lu et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Lu, Zeyuan
Liu, Na
Wang, Feng
Epigenetic Regulations in Diabetic Nephropathy
title Epigenetic Regulations in Diabetic Nephropathy
title_full Epigenetic Regulations in Diabetic Nephropathy
title_fullStr Epigenetic Regulations in Diabetic Nephropathy
title_full_unstemmed Epigenetic Regulations in Diabetic Nephropathy
title_short Epigenetic Regulations in Diabetic Nephropathy
title_sort epigenetic regulations in diabetic nephropathy
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5376412/
https://www.ncbi.nlm.nih.gov/pubmed/28401169
http://dx.doi.org/10.1155/2017/7805058
work_keys_str_mv AT luzeyuan epigeneticregulationsindiabeticnephropathy
AT liuna epigeneticregulationsindiabeticnephropathy
AT wangfeng epigeneticregulationsindiabeticnephropathy